What is the role of current mass spectrometry in pharmaceutical analysis?
Mass Spectrometry Reviews · 2024-05 · 43 (3) · 560-609
DOI: 10.1002/mas.21858 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Mass Spectrometry Reviews, online erschienen am 28.07.2023. Verfasst von Maria Khalikova und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Analytical Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic. Hauptthemen laut MEDLINE: Drug Discovery, Biological Products. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 388 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The role of mass spectrometry (MS) has become more important in most application domains in recent years. Pharmaceutical analysis is specific due to its stringent regulation procedures, the need for good laboratory/manufacturing practices, and a large number of routine quality control analyses to be carried out. The role of MS is, therefore, very different throughout the whole drug development cycle. While it dominates within the drug discovery and development phase, in routine quality control, the role of MS is minor and indispensable only for selected applications. Moreover, its role is very different in the case of analysis of small molecule pharmaceuticals and biopharmaceuticals. Our review explains the role of current MS in the analysis of both small‐molecule chemical drugs and biopharmaceuticals. Important features of MS‐based technologies being implemented, method requirements, and related challenges are discussed. The differences in analytical procedures for small molecule pharmaceuticals and biopharmaceuticals are pointed out. While a single method or a small set of methods is usually sufficient for quality control in the case of small molecule pharmaceuticals and MS is often not indispensable, a large panel of methods including extensive use of MS must be used for quality control of biopharmaceuticals. Finally, expected development and future trends are outlined.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Analytical Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic.
- Department of Chemistry, Faculty of Science, University of Hradec Králové, Hradec Králové, Czech Republic.
- Department of Analytical Chemistry, Faculty of Chemical Engineering, UCT Prague, Prague, Czech Republic.
- Department of Development, Zentiva, k. s., Praha, Praha, Czech Republic.
- Department of Pharmaceutical Chemistry and Pharmaceutical Analysis, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic.
Zitieren
APA
Khalikova, M., Jireš, J., Horáček, O., Douša, M., Kučera, R., & Nováková, L. (2024). What is the role of current mass spectrometry in pharmaceutical analysis?. Mass Spectrometry Reviews, 43(3), 560-609. https://doi.org/10.1002/mas.21858
Vancouver
Khalikova M, Jireš J, Horáček O, Douša M, Kučera R, Nováková L. What is the role of current mass spectrometry in pharmaceutical analysis?. Mass Spectrometry Reviews. 2024;43(3):560-609. doi:10.1002/mas.21858
BibTeX
@article{Khalikova2024,
author = {Khalikova, Maria and Jireš, Jakub and Horáček, Ondřej and Douša, Michal and Kučera, Radim and Nováková, Lucie},
title = {What is the role of current mass spectrometry in pharmaceutical analysis?},
journal = {Mass Spectrometry Reviews},
year = {2024},
volume = {43},
number = {3},
pages = {560--609},
doi = {10.1002/mas.21858}
}
EUVIMED